Alteration in Bone Metabolism Markers Fallowing 3-Months Insulin Therapy in Patients with Type 2 Diabetes Mellitus: Analogues Vs. Human Insulins

dc.contributor.author	Şahin, İbrahim
dc.contributor.author	Karaca, Zuhal
dc.contributor.author	Taskapan, Çağatay
dc.contributor.author	Özyalin, Fatma
dc.contributor.author	Yoloğlu, Saim
dc.date.accessioned	2020-07-07T09:23:45Z
dc.date.available	2020-07-07T09:23:45Z
dc.date.issued	2014
dc.identifier.citation	Sahin, I., Karaca, Z., Taskapan, C., Ozyalin, F., Yologlu, S. Alteration in Bone Metabolism Markers Fallowing 3-Months Insulin Therapy in Patients with Type 2 Diabetes Mellitus: Analogues Vs. Human Insulins. (2014). ENDOCRINE REVIEWS.	tr_TR
dc.identifier.issn	0163-769X
dc.identifier.issn	1945-7189
dc.identifier.uri	http://abakus.inonu.edu.tr/xmlui/handle/123456789/16557
dc.description	ENDOCRINE REVIEWS Volume: 35 Issue: 3 Supplement: S Meeting Abstract: SAT-0974 Published: JUN 2014 Document Type:Meeting Abstract	tr_TR
dc.language.iso	en	tr_TR
dc.publisher	ENDOCRINE SOC,	tr_TR
dc.title	Alteration in Bone Metabolism Markers Fallowing 3-Months Insulin Therapy in Patients with Type 2 Diabetes Mellitus: Analogues Vs. Human Insulins	tr_TR
dc.type	Article	tr_TR